Moolec Science (MLECW) Dividends Paid - Common (2022 - 2024)
Moolec Science (MLECW) posted Dividends Paid - Common of -$72051.0 for Q4 2024, down 102.0% sequentially from $3.6 million in Q3 2024, and up 52.48% YoY from -$47253.8 in Q1 2024.
Moolec Science (MLECW) Dividends Paid - Common (2022 - 2024) Analysis & Trends
Moolec Science has reported Dividends Paid - Common for 3 years, with the latest figure at -$72051.0 in Q4 2024.
- Quarterly Dividends Paid - Common rose 52.48% year-over-year to -$72051.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $2.0 million (up 121.69% YoY) and the FY2025 annual result came in at $72051.0, down 58.78% from the prior year.
- Dividends Paid - Common eased to -$72051.0 in Q4 2024 per MLECW's latest filing, from $3.6 million in the prior quarter.
- Over five years, Dividends Paid - Common peaked at $9.3 million in Q4 2022 and troughed at -$5.8 million in Q2 2023.
- A 3-year average of $384102.2 and a median of $853594.0 in 2023 frame the typical range for Dividends Paid - Common.
- The sharpest annual moves came in 2023 and 2024: Dividends Paid - Common tumbled 497.23% in 2023, then surged 322.93% in 2024.
- Over 3 years, Dividends Paid - Common stood at $9.3 million in 2022, then sank by 101.62% to -$151612.0 in 2023, then surged by 52.48% to -$72051.0 in 2024.
- According to Business Quant data, Dividends Paid - Common over the past three periods registered -$72051.0, $3.6 million, and -$4.1 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 34.60 Mn |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -72,051.00 |
| Dec 31, 2024 | -72,051.00 |
| Sep 30, 2024 | 3.61 Mn |
| Sep 30, 2024 | 3.61 Mn |
| Jun 30, 2024 | -4.08 Mn |
| Jun 30, 2024 | -4.08 Mn |
| Mar 31, 2024 | 2.55 Mn |
| Mar 31, 2024 | 2.55 Mn |
| Dec 31, 2023 | -151,612.00 |
| Dec 31, 2023 | -151,612.00 |
| Sep 30, 2023 | 853,594.00 |
| Sep 30, 2023 | 853,594.00 |
| Jun 30, 2023 | -5.77 Mn |
| Jun 30, 2023 | -5.77 Mn |
| Mar 31, 2023 | -4.21 Mn |
| Mar 31, 2023 | -4.21 Mn |
| Dec 31, 2022 | 9.34 Mn |
| Dec 31, 2022 | 9.34 Mn |
| Sep 30, 2022 | 1.09 Mn |
| Sep 30, 2022 | 1.09 Mn |